Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
8.01
-0.15 (-1.84%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $527.23 million as of September 25, 2026. Its market cap has increased by 85.73% in one year.
Market Cap
527.23M
Enterprise Value
422.87M
1-Year Change
85.73%
Ranking
Category
Stock Price
$8.01
ChartMarket Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $527.23M, an increase of 755.64%. That is a compound annual growth rate of 47.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 527.23M | 38.30% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 603.55M |
| Allogene Therapeutics | 590.79M |
| AgomAb Therapeutics NV | 565.86M |
| Arvinas | 556.44M |
| ProKidney | 553.25M |
| Capricor Therapeutics | 543.02M |
| Autolus Therapeutics | 540.31M |
| Ovid Therapeutics | 539.02M |